Steviolbioside
- Generic Name
- Steviolbioside
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C32H50O13
- CAS Number
- 41093-60-1
- Unique Ingredient Identifier
- 07GV37SOFN
- Background
Steviolbioside has been used in trials studying the treatment of HIV-1 Infection.
- Associated Conditions
- -
- Associated Therapies
- -
Renal Effect of Stribild or Other Tenofovir DF-containing Regimens Compared to Ritonavir-boosted Atazanavir Plus Abacavir/Lamivudine in Antiretroviral Treatment-naive HIV-1 Infected Adults
Phase 4
Completed
- Conditions
- HIV-1 Infection
- Interventions
- First Posted Date
- 2014-09-23
- Last Posted Date
- 2018-01-03
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 72
- Registration Number
- NCT02246998
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath